189 related articles for article (PubMed ID: 1875495)
1. Effect of meal on the physiological and physicochemical actions of potassium citrate.
Pak CY; Oh MS; Baker S; Morris JS
J Urol; 1991 Sep; 146(3):803-5. PubMed ID: 1875495
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of calcium nephrolithiasis with potassium citrate.
Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
[TBL] [Abstract][Full Text] [Related]
3. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
4. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
5. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
Preminger GM; Sakhaee K; Pak CY
J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
[TBL] [Abstract][Full Text] [Related]
6. Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction.
Lindberg J; Harvey J; Pak CY
J Urol; 1990 Feb; 143(2):248-51. PubMed ID: 2299712
[TBL] [Abstract][Full Text] [Related]
7. Effect of orange juice consumption on urinary stone risk factors.
Wabner CL; Pak CY
J Urol; 1993 Jun; 149(6):1405-8. PubMed ID: 8501777
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
Pak CY; Peterson R
Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
Pak CY; Fuller C
Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
[TBL] [Abstract][Full Text] [Related]
10. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
Preminger GM; Sakhaee K; Skurla C; Pak CY
J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
[TBL] [Abstract][Full Text] [Related]
11. Successful management of uric acid nephrolithiasis with potassium citrate.
Pak CY; Sakhaee K; Fuller C
Kidney Int; 1986 Sep; 30(3):422-8. PubMed ID: 3784284
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
Sakhaee K; Nicar M; Hill K; Pak CY
Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
[TBL] [Abstract][Full Text] [Related]
13. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
14. Citrate and renal calculi: an update.
Pak CY
Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
[TBL] [Abstract][Full Text] [Related]
15. Alkali absorption and citrate excretion in calcium nephrolithiasis.
Sakhaee K; Williams RH; Oh MS; Padalino P; Adams-Huet B; Whitson P; Pak CY
J Bone Miner Res; 1993 Jul; 8(7):789-94. PubMed ID: 8352061
[TBL] [Abstract][Full Text] [Related]
16. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
17. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis.
Nicar MJ; Peterson R; Pak CY
J Urol; 1984 Mar; 131(3):430-3. PubMed ID: 6699979
[TBL] [Abstract][Full Text] [Related]
18. Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting.
Nicar MJ; Hsu MC; Fetner C
Clin Ther; 1986; 8(2):219-25. PubMed ID: 3698069
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical action of potassium-magnesium citrate in nephrolithiasis.
Pak CY; Koenig K; Khan R; Haynes S; Padalino P
J Bone Miner Res; 1992 Mar; 7(3):281-5. PubMed ID: 1585829
[TBL] [Abstract][Full Text] [Related]
20. Graphic display of urinary risk factors for renal stone formation.
Pak CY; Skurla C; Harvey J
J Urol; 1985 Nov; 134(5):867-70. PubMed ID: 4057368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
